Literature DB >> 11322167

NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issues.

B Perbal1.   

Abstract

The CCN family of genes presently consists of six distinct members encoding proteins that participate in fundamental biological processes such as cell proliferation, attachment, migration, differentiation, wound healing, angiogenesis, and several pathologies including fibrosis and tumorigenesis. Whereas CYR61 and CTGF were reported to act as positive regulators of cell growth, NOV (nephroblastoma overexpressed) provided the first example of a CCN protein with negative regulatory properties and the first example of aberrant expression being associated with tumour development. The subsequent discovery of the ELM1, rCOP1, and WISP proteins has broadened the variety of functions attributed to the CCN proteins and has extended previous observations to other biological systems. This review discusses fundamental questions regarding the regulation of CCN gene expression in normal and pathological conditions, and the structural basis for their specific biological activity. After discussing the role of nov and other CCN proteins in the development of a variety of different tissues such as kidney, nervous system, muscle, cartilage, and bone, the altered expression of the CCN proteins in various pathologies is discussed, with an emphasis on the altered expression of nov in many different tumour types such as Wilms's tumour, renal cell carcinomas, prostate carcinomas, osteosarcomas, chondrosarcomas, adrenocortical carcinomas, and neuroblastomas. The possible use of nov as a tool for molecular medicine is also discussed. The variety of biological functions attributed to the CCN proteins has led to the proposal of a model in which physical interactions between the amino and carboxy portions of the CCN proteins modulate their biological activity and ensure a proper balance of positive and negative signals through interactions with other partners. In this model, disruption of the secondary structure of the CCN proteins induced by deletions of either terminus is expected to confer on the truncated polypeptide constitutive positive or negative activities.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11322167      PMCID: PMC1187006          DOI: 10.1136/mp.54.2.57

Source DB:  PubMed          Journal:  Mol Pathol        ISSN: 1366-8714


  70 in total

1.  Expression of immediate early gene cyr61 during the differentiation of immortalized embryonic hippocampal neuronal cells.

Authors:  K C Chung; Y S Ahn
Journal:  Neurosci Lett       Date:  1998-10-23       Impact factor: 3.046

2.  Identification of rCop-1, a new member of the CCN protein family, as a negative regulator for cell transformation.

Authors:  R Zhang; L Averboukh; W Zhu; H Zhang; H Jo; P J Dempsey; R J Coffey; A B Pardee; P Liang
Journal:  Mol Cell Biol       Date:  1998-10       Impact factor: 4.272

3.  A developmental study of novH gene expression in human central nervous system.

Authors:  B Y Su; W Q Cai; C G Zhang; H C Su; B Perbal
Journal:  C R Acad Sci III       Date:  1998-11

4.  Identification and cloning of a connective tissue growth factor-like cDNA from human osteoblasts encoding a novel regulator of osteoblast functions.

Authors:  S Kumar; A T Hand; J R Connor; R A Dodds; P J Ryan; J J Trill; S M Fisher; M E Nuttall; D B Lipshutz; C Zou; S M Hwang; B J Votta; I E James; D J Rieman; M Gowen; J C Lee
Journal:  J Biol Chem       Date:  1999-06-11       Impact factor: 5.157

5.  Cloning of a mRNA preferentially expressed in chondrocytes by differential display-PCR from a human chondrocytic cell line that is identical with connective tissue growth factor (CTGF) mRNA.

Authors:  T Nakanishi; Y Kimura; T Tamura; H Ichikawa; Y Yamaai; T Sugimoto; M Takigawa
Journal:  Biochem Biophys Res Commun       Date:  1997-05-08       Impact factor: 3.575

6.  Overexpression of connective tissue growth factor gene induces apoptosis in human aortic smooth muscle cells.

Authors:  K Hishikawa; B S Oemar; F C Tanner; T Nakaki; T Fujii; T F Lüscher
Journal:  Circulation       Date:  1999-11-16       Impact factor: 29.690

7.  Plasminogen activator inhibitor type-2 (PAI-2) gene transcription requires a novel NF-kappaB-like transcriptional regulatory motif.

Authors:  D Mahony; B Kalionis; T M Antalis
Journal:  Eur J Biochem       Date:  1999-08

Review 8.  Pathogenic potential of myeloblastosis-associated viruses.

Authors:  B Perbal
Journal:  Infect Agents Dis       Date:  1995-12

9.  Demonstration of receptors specific for connective tissue growth factor on a human chondrocytic cell line (HCS-2/8).

Authors:  T Nishida; T Nakanishi; T Shimo; M Asano; T Hattori; T Tamatani; K Tezuka; M Takigawa
Journal:  Biochem Biophys Res Commun       Date:  1998-06-29       Impact factor: 3.575

10.  Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair.

Authors:  A Igarashi; H Okochi; D M Bradham; G R Grotendorst
Journal:  Mol Biol Cell       Date:  1993-06       Impact factor: 4.138

View more
  123 in total

1.  Report on the second international workshop on the CCN family of genes.

Authors:  B Perbal; D R Brigstock; L F Lau
Journal:  Mol Pathol       Date:  2003-04

2.  CCN3: the-pain-killer inside me.

Authors:  Bernard Perbal
Journal:  J Cell Commun Signal       Date:  2012-03-30       Impact factor: 5.782

Review 3.  The role of connective tissue growth factor (CTGF/CCN2) in skeletogenesis.

Authors:  John A Arnott; Alex G Lambi; Christina Mundy; Honey Hendesi; Robin A Pixley; Thomas A Owen; Fayez F Safadi; Steven N Popoff
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2011       Impact factor: 1.807

Review 4.  The CCN proteins: important signaling mediators in stem cell differentiation and tumorigenesis.

Authors:  Guo-Wei Zuo; Christopher D Kohls; Bai-Cheng He; Liang Chen; Wenli Zhang; Qiong Shi; Bing-Qiang Zhang; Quan Kang; Jinyong Luo; Xiaoji Luo; Eric R Wagner; Stephanie H Kim; Farbod Restegar; Rex C Haydon; Zhong-Liang Deng; Hue H Luu; Tong-Chuan He; Qing Luo
Journal:  Histol Histopathol       Date:  2010-06       Impact factor: 2.303

5.  The role of tumor cell-derived connective tissue growth factor (CTGF/CCN2) in pancreatic tumor growth.

Authors:  Kevin L Bennewith; Xin Huang; Christine M Ham; Edward E Graves; Janine T Erler; Neeraja Kambham; Jonathan Feazell; George P Yang; Albert Koong; Amato J Giaccia
Journal:  Cancer Res       Date:  2009-02-01       Impact factor: 12.701

Review 6.  Caught between a "Rho" and a hard place: are CCN1/CYR61 and CCN2/CTGF the arbiters of microvascular stiffness?

Authors:  Brahim Chaqour
Journal:  J Cell Commun Signal       Date:  2019-08-02       Impact factor: 5.782

7.  alpha2-antiplasmin is associated with the progression of fibrosis.

Authors:  Yosuke Kanno; Eri Kawashita; Misato Minamida; Aki Kaneiwa; Kiyotaka Okada; Shigeru Ueshima; Osamu Matsuo; Hiroyuki Matsuno
Journal:  Am J Pathol       Date:  2009-12-11       Impact factor: 4.307

8.  Dual roles of CCN proteins in breast cancer progression.

Authors:  Celina G Kleer
Journal:  J Cell Commun Signal       Date:  2016-08-12       Impact factor: 5.782

9.  Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development.

Authors:  Sanja Ivkovic; Byeong S Yoon; Steven N Popoff; Fayez F Safadi; Diana E Libuda; Robert C Stephenson; Aaron Daluiski; Karen M Lyons
Journal:  Development       Date:  2003-06       Impact factor: 6.868

10.  Connective tissue growth factor as a mediator of intraocular fibrosis.

Authors:  Shikun He; Youxin Chen; Rima Khankan; Ernesto Barron; Richard Burton; Danhong Zhu; Stephen J Ryan; Noelynn Oliver; David R Hinton
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-04-30       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.